J&J supports Optometry Giving Sight

Article

Johnson & Johnson Vision Care will support Optometry Giving Sight at the silver level, according to a statement from Dr. Mary Anne Murphy, chair of Optometry Giving Sight

Golden, CO - Johnson & Johnson Vision Care will support Optometry Giving Sight at the silver level, according to a statement from Dr. Mary Anne Murphy, Chair of Optometry Giving Sight.

“We are delighted that Johnson & Johnson Vision Care has joined our campaign to help ensure that people in underserved communities can gain access to affordable, long-term vision care services delivered by locally trained eye-care professionals,” she said.

Optometry Giving Sight was created in 2003 and is the only global fundraising initiative that specifically targets the prevention of blindness and impaired vision due to uncorrected refractive error.

Dr. Murphy noted that while there are still an estimated 600 million people with refractive error blindness or impaired vision, the optometric profession and industry are being increasingly recognized for the leadership role they are playing in helping to eliminate this backlog.

“Through this charity, we continue to see many lives change for the better,” said Dr. Richard Wallingford, Director of Professional Affairs, Vistakon Division of Johnson & Johnson Vision Care, Inc. “Each year Optometry Giving Sight continues to advance its mission to improve the quality of life of people who are needlessly blind or vision impaired simply because they do not have access to an eye exam or a pair of glasses.”

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Dr Neda Shamie speaks on cataract and refractive surgery at CIME 2025
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
What to know about legislative moves that have been made through May this year.
CIME 25: Dilsher Dhoot, MD, FASRS, is excited about emerging retinal therapies.
Robert Maloney, MD, MA, at the 2025 Controversies in Modern Eye Care meeting
Dr Jacob Lang at the 2025 Controversies in Modern Eye Care meeting
Steven Ferrucci, OD, FAAO, at Controversies in Modern Eyecare 2025
© 2025 MJH Life Sciences

All rights reserved.